TARS - Tarsus Pharmaceuticals Inc
IEX Last Trade
27.05
-0.550 -2.033%
Share volume: 636,703
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$27.60
-0.55
-1.99%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-09 | 2023-03-17 | 2023-05-09 | 2023-08-10 | 2023-11-09 | 2024-02-27 | 2024-05-08 | |
| Total revenue | 15.277 M | 0.000 | 10.000 M | 2.500 M | 0.000 | 1.871 M | 13.076 M | 27.614 M | |
| Cost of revenue | 522.000 K | 0.000 | 400.000 K | 0.000 | 0.000 | 377.000 K | 1.216 M | 1.654 M | |
| Gross profit | 14.755 M | 0.000 | 9.600 M | 2.500 M | 0.000 | 1.494 M | 11.860 M | 25.960 M | |
| -100.00% | inf% | -73.96% | -100.00% | inf% | 693.84% | 118.89% | |||
| Operating expenses | 19.979 M | 22.906 M | 24.661 M | 27.452 M | 32.821 M | 42.429 M | 56.310 M | 63.644 M | |
| Selling general and admin | 10.376 M | 11.994 M | 14.633 M | 15.096 M | 20.275 M | 30.324 M | 43.005 M | 51.578 M | |
| Research and development | 9.603 M | 10.912 M | 10.028 M | 12.356 M | 12.546 M | 12.105 M | 13.305 M | 12.066 M | |
| Total expenses | 20.501 M | 22.906 M | 25.061 M | 27.452 M | 32.821 M | 42.806 M | 57.526 M | 65.298 M | |
| 11.73% | 9.41% | 9.54% | 19.56% | 30.42% | 34.39% | 13.51% | |||
| Operating income | -5.224 M | -22.906 M | -15.061 M | -24.952 M | -32.821 M | -40.935 M | -44.450 M | -37.684 M | |
| Ebit | -5.224 M | -22.906 M | -15.061 M | -24.952 M | -32.821 M | -40.935 M | -44.450 M | -37.684 M | |
| Pretax income | -5.743 M | -22.516 M | -13.599 M | -23.419 M | -31.424 M | -39.148 M | -41.902 M | -35.731 M | |
| 292.06% | -39.60% | 72.21% | 34.18% | 24.58% | 7.03% | -14.73% | |||
| Income tax | 0.000 | -5.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -5.743 M | -22.511 M | -13.599 M | -23.419 M | -31.424 M | -39.148 M | -41.902 M | -35.731 M | |
| -291.97% | 39.59% | -72.21% | -34.18% | -24.58% | -7.03% | 14.73% | |||
| Net income | -5.743 M | -22.511 M | -13.599 M | -23.419 M | -31.424 M | -39.148 M | -41.902 M | -35.731 M | |
| -291.97% | 39.59% | -72.21% | -34.18% | -24.58% | -7.03% | 14.73% |